Frank, Rimerman Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1977560 Palo Alto, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$4,458,033

-$434,550 QoQ

Shares Held

35,286

+0.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#607

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Frank, Rimerman Advisors LLC holds $61,050,050 across 13 Drug Manufacturers - General names. GILD ranks #5 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,066	$13,272,893
2	JNJ	Johnson & Johnson	51,668	$13,122,121
3	ABBV	AbbVie Inc.	34,526	$8,688,122
4	MRK	Merck & Co., Inc.	37,710	$4,845,735
5	GILD	Gilead Sciences, Inc. This page	35,286	$4,458,033
6	PFE	Pfizer Inc	164,115	$3,951,889
7	BMY	Bristol Myers Squibb Co	50,290	$2,897,709
8	AMGN	Amgen Inc	7,272	$2,633,336

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,458,033	35,286	+0.5%	Shares	Sole	2026-07-27
2026-03-31	$4,892,583	35,105	0.0%	Shares	Sole	2026-04-29
2025-12-31	$4,308,787	35,105	+0.2%	Shares	Sole	2026-01-15
2025-09-30	$3,887,331	35,021	+9.2%	Shares	Sole	2025-11-04
2025-06-30	$3,556,598	32,079	-2.1%	Shares	Sole	2025-08-11
2025-03-31	$3,671,206	32,764	+1.4%	Shares	Sole	2025-05-12
2024-12-31	$2,985,213	32,318	+0.7%	Shares	Sole	2025-02-10
2024-09-30	$2,690,090	32,086	+7.5%	Shares	Sole	2024-10-24
2024-06-30	$2,046,910	29,834	+4496.9%	Shares	Sole	2024-08-13
2024-03-31	$47,539	649	+47.2%	Shares	Sole	2024-05-09
2023-12-31	$35,725	441	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.